1. Magnetic resonance imaging of dilated cardiomyopathy: prognostic benefit of identifying late gadolinium enhancement in Asian patients
- Author
-
Swee Tian Quek, Devinder Singh, Pipin Kojodjojo, Ching Ching Ong, Ping Chai, Swee Chong Seow, Wee Tiong Yeo, Anna Nogue Infante, Alfred Yip, Ying Hao Lim, Toon Wei Lim, Lynette Teo, and Christopher Chieh Yang Koo
- Subjects
Cardiomyopathy, Dilated ,Male ,medicine.medical_specialty ,Contrast Media ,Magnetic Resonance Imaging, Cine ,Gadolinium ,Ventricular Function, Left ,Predictive Value of Tests ,Internal medicine ,Myocardial scarring ,Clinical endpoint ,Medicine ,Humans ,cardiovascular diseases ,Ejection fraction ,medicine.diagnostic_test ,business.industry ,Hazard ratio ,Magnetic resonance imaging ,Dilated cardiomyopathy ,Stroke Volume ,General Medicine ,Gold standard (test) ,medicine.disease ,Prognosis ,Magnetic Resonance Imaging ,Heart failure ,embryonic structures ,Cardiology ,cardiovascular system ,Female ,Original Article ,medicine.symptom ,business - Abstract
INTRODUCTION Risk stratification in dilated cardiomyopathy (DCM) is imprecise, relying largely on echocardiographic left ventricular ejection fraction (LVEF) and severity of heart failure symptoms. Adverse cardiovascular events are increased by the presence of myocardial scarring. Late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) imaging is the gold standard for identifying myocardial scars. We examined the association between LGE on CMR imaging and adverse clinical outcomes during long-term follow-up of Asian patients with DCM. METHODS Consecutive patients with DCM undergoing CMR imaging at a single Asian academic medical centre between 2005 and 2015 were recruited. Clinical outcomes were tracked using comprehensive electronic medical records and mortality was determined by cross-linkages with national registries. Presence and distribution of LGE on CMR imaging were determined by investigators blinded to patient outcomes. Primary endpoint was a composite of heart failure hospitalisations, appropriate implantable cardioverter-defibrillator shocks and cardiovascular mortality. RESULTS Of 86 patients, 64.0% had LGE (80.2% male; mean LVEF 30.1% ± 12.7%). Mid-wall fibrosis (71.7%) was the most common pattern of LGE distribution. Over a mean follow-up period of 4.9 ± 3.2 years, 19 (34.5%) patients with LGE reached the composite endpoint compared to 4 (12.9%) patients without LGE (p = 0.01). Presence of LGE, but not echocardiographic LVEF, independently predicted the primary endpoint (hazard ratio 4.15 [95% confidence interval 1.28โ13.50]; p = 0.02). CONCLUSION LGE presence independently predicted adverse clinical events in Asian patients with DCM. Routine use of CMR imaging to characterise the myocardial substrate is recommended for enhanced risk stratification and should strongly influence clinical management.
- Published
- 2019